Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patients.
about
Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancerAdditional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patientsBeta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis.Cost-effectiveness of ceftazidime or imipenem/cilastatin versus ceftriaxone + aminoglycoside in the treatment of febrile episodes in neutropenic cancer patients in Germany.Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study.Antibiotic combinations: should they be tested?Nosocomial epiglottitis associated with penicillin- and cephalosporin-resistant Streptococcus pneumoniae bacteremia.Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.Controversies in the management of febrile neutropenic cancer patients.Aminoglycosides: current role in antimicrobial therapy.Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia.A randomised comparison of ceftazidime and piperacillin, both in combination with flucloxacillin for treatment of febrile episodes in neutropenic children. Finnish Three-Centre Study.A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin.Once daily antibiotic regimen in paediatric oncology.
P2860
Q24201136-CC9A0ACC-4778-4985-8AD6-D5F0AD1521DBQ24246468-B5C4DBC1-1D78-4A6F-AB7B-FF194CB51D6FQ31143077-1479BDC5-9346-4CDD-AB90-2F4F5355F1C2Q33535030-29122C60-B302-457A-B7DB-E7E1F303E75DQ35540674-0E4B023A-6BA5-4D54-9750-30E4E953240DQ35836302-817463B2-0341-4785-8DA6-08618ECCDA15Q36632795-4D3EFE95-CAEB-4683-B1CC-01E540C52C19Q37070605-90A10B33-35E9-49F4-805C-B27567A16C9CQ38747206-5B26A216-E04D-457A-ACCB-AE0078D663F6Q39603225-B9871F1D-3B03-4CDB-A6E0-1C387ED9C214Q39608639-08DA6EB8-0E2C-4D80-9C16-0A82BDBE2BC8Q40755952-705F49B8-FA86-43CF-AA83-683BD754A65EQ40767303-9B8DB8C5-429A-4A36-A81D-D90C6FE6098AQ40770561-1006927D-DD32-439F-84AB-A492EEE2F890Q42011952-EFA2FF23-E8BD-4591-8108-49241C493850
P2860
Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patients.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Randomized comparison between ...... nulocytopenic cancer patients.
@ast
Randomized comparison between ...... nulocytopenic cancer patients.
@en
type
label
Randomized comparison between ...... nulocytopenic cancer patients.
@ast
Randomized comparison between ...... nulocytopenic cancer patients.
@en
prefLabel
Randomized comparison between ...... nulocytopenic cancer patients.
@ast
Randomized comparison between ...... nulocytopenic cancer patients.
@en
P2093
P2860
P356
P1476
Randomized comparison between ...... nulocytopenic cancer patients.
@en
P2093
P2860
P356
10.1128/AAC.30.1.64
P407
P577
1986-07-01T00:00:00Z